Skip to main content
. Author manuscript; available in PMC: 2023 Jun 6.
Published in final edited form as: Circ Heart Fail. 2022 Jun 6;15(6):e008706. doi: 10.1161/CIRCHEARTFAILURE.121.008706

Figure 3. Survival by RHF groups for patients who are alive at 1 month post-implant according to number of RHF manifestations.

Figure 3.

Figure 3.

Panel A. No vs one vs two vs three RHF manifestations. Panel B. No vs one vs more than one RHF manifestations. Patients alive at 1 month were N=5176. Event was death censored at transplant, recovery or exchange. Patients with vena cava distension (n=17, deaths=8) and patients with missing RHF information (n=329, deaths=75) were excluded from the analysis.